Health & Biotech
Why Nanollose is on the verge of a major market opportunity with its fibre conversion technology, as global fashion brands come knocking
The UK’s love affair with Aussie medicinal cannabis blooms as ECS exports first dried flower shipment
ASX Health Stocks: Opthea presents data at global conference; CardieX to progress Philip Morris sponsored study
Dr Boreham’s Crucible: Does EBR have the ticker to tackle the charge cable conundrum?
ASX Health Stocks: ACCC gives the OK for API takeover by Wesfarmers
Science journal Nature reveals decade-long remissions; sparks hope for curative potential of CAR-T treatment
Creso Pharma welcomes legendary Canadian founder, investing leader and CBD entrepreneur Bruce Linton
Government backs Singular Health innovation with $305k R&D tax fund
Morgans: This incredible Aussie medtech is trading at just ⅓ its real value
ASX Health Stocks: dorsaVi gets ISO certification; Actinogen to begin Phase 2 trial
ASX Health Stocks: NeuroScientific gains on study news; FDA report gives Auscann a boost
ASX Health Stocks: Resonance gets green light in US
ASX Health Stocks: PIQ leaps 9pc on blood test results; Respiri gains 6pc on Wheezo order
ASX Health Stocks: OncoSil up 15pc on German device funding; Starpharma expands to Middle East
Creso Pharma stakes its claim of the multibillion US CBD market in landmark acquisition
Check Up: Moderna trials mRNA-based HIV vaccine, while these ASX biotechs get patents
How Exopharm LEAP technology is fuelling accelerated development of immune-silent, precision delivery of next-generation, exo-medicines
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
